Zamifenacin (UK-76, 654), a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome |
| |
| Authors: | L. A. Houghton,J. Rogers,P. J. Whorwell,F. C. Campbell,N. S. Williams,& J. Goka |
| |
| Affiliation: | Department of Medicine, University Hospital of South Manchester, Manchester, UK,;Department of Surgery, Royal London Hospital, London, UK,;Department of Surgery, Ninewells Hospital, Dundee, UK,;Pfizer Central Research, Sandwich, Kent, UK |
| |
| Abstract: | |
| |
| Keywords: | |
|
|
